Analysis of drugs, healthcare schemes, a study on nutritional improvement in hemodialysis patients at tertiary care hospital.
Not Applicable
- Conditions
- Health Condition 1: N185- Chronic kidney disease, stage 5
- Registration Number
- CTRI/2019/08/020874
- Lead Sponsor
- J Gangadhar Naik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Only Haemodialysis Patients
Patients aged only above 18 years
Patients who are willing to participate in this study.
Ability to speak and understand English or Kannada language
Being conscious and cooperative
Exclusion Criteria
Patients on haemodialysis for ARF (Acute Renal Failure)
Patients not willing to give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall understanding of various drugs used in the management of CKD, its complications and other comorbid diseases associated with it, will help the clinical pharmacists, physicians in better management of patients, as far as adverse effects, costs, toxicities etc., of the drugs concerned. Thereby improving patient compliance to therapy and overall outcome of CKD pharmacotherapy. <br/ ><br> <br/ ><br>Timepoint: One year
- Secondary Outcome Measures
Name Time Method A thorough understanding about healthcare schemes with their benefits which would help Hemodialysis patients to make an informed choice before opting for a scheme.Timepoint: 6 months;Cost-effective model would help not only physicians but also patientsâ?? hemodialysis patients in choosing a therapeutic option.Timepoint: 6 months;May improve the nutritional status, knowledge and skills of the haemodialysis patients toward their disease and dietary management due to nutrition education program.Timepoint: one year